IRIS Accounts Production v24.1.0.578 05279113 director 1.12.22 30.11.23 30.11.23 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh052791132022-11-30052791132023-11-30052791132022-12-012023-11-30052791132021-11-30052791132021-12-012022-11-30052791132022-11-3005279113ns14:PoundSterling2022-12-012023-11-3005279113ns10:Director12022-12-012023-11-3005279113ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3005279113ns10:SmallEntities2022-12-012023-11-3005279113ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3005279113ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3005279113ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3005279113ns10:FullAccounts2022-12-012023-11-3005279113ns10:OrdinaryShareClass12022-12-012023-11-3005279113ns10:OrdinaryShareClass22022-12-012023-11-3005279113ns5:CurrentFinancialInstruments2023-11-3005279113ns5:CurrentFinancialInstruments2022-11-3005279113ns5:ShareCapital2023-11-3005279113ns5:ShareCapital2022-11-3005279113ns5:RetainedEarningsAccumulatedLosses2023-11-3005279113ns5:RetainedEarningsAccumulatedLosses2022-11-3005279113ns10:RegisteredOffice2022-12-012023-11-3005279113ns5:FurnitureFittings2022-11-3005279113ns5:FurnitureFittings2023-11-3005279113ns5:FurnitureFittings2022-11-3005279113ns5:Non-currentFinancialInstruments2023-11-3005279113ns5:Non-currentFinancialInstruments2022-11-3005279113ns10:OrdinaryShareClass12023-11-3005279113ns10:OrdinaryShareClass22023-11-30052791131ns10:Director12022-11-30052791131ns10:Director12021-11-30052791131ns10:Director12022-12-012023-11-30052791131ns10:Director12021-12-012022-11-30052791131ns10:Director12023-11-30052791131ns10:Director12022-11-30
REGISTERED NUMBER: 05279113















Unaudited Financial Statements for the Year Ended 30th November 2023

for

Immunoclot Ltd

Immunoclot Ltd (Registered number: 05279113)






Contents of the Financial Statements
for the Year Ended 30th November 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


Immunoclot Ltd (Registered number: 05279113)

Balance Sheet
30th November 2023

30.11.23 30.11.22
Notes £    £   
CURRENT ASSETS
Debtors 5 51,124 50,324
Cash at bank 2,023 1,841
53,147 52,165
CREDITORS
Amounts falling due within one year 6 6,832 6,204
NET CURRENT ASSETS 46,315 45,961
TOTAL ASSETS LESS CURRENT
LIABILITIES

46,315

45,961

CAPITAL AND RESERVES
Called up share capital 7 99 99
Retained earnings 46,216 45,862
SHAREHOLDERS' FUNDS 46,315 45,961

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 30th August 2024 and were signed by:





Dr P R J Ames - Director


Immunoclot Ltd (Registered number: 05279113)

Notes to the Financial Statements
for the Year Ended 30th November 2023

1. COMPANY INFORMATION

Immunoclot Ltd is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address are as below:

Registered number: 05279113

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Going concern
The company has received no income during the year due to IR35 regulation changes. However, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Immunoclot Ltd (Registered number: 05279113)

Notes to the Financial Statements - continued
for the Year Ended 30th November 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st December 2022
and 30th November 2023 881
DEPRECIATION
At 1st December 2022
and 30th November 2023 881
NET BOOK VALUE
At 30th November 2023 -
At 30th November 2022 -

5. DEBTORS
30.11.23 30.11.22
£    £   
Amounts falling due within one year:
Other debtors 50,112 50,324

Amounts falling due after more than one year:
Other debtors 1,012 -

Aggregate amounts 51,124 50,324

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Tax 83 -
Directors' current accounts 6,749 6,204
6,832 6,204

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.23 30.11.22
value: £    £   
50 Ordinary A 1 50 50
49 Ordinary B 1 49 49
99 99

The Ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The Ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in respect of dividend and capital distribution rights.

Immunoclot Ltd (Registered number: 05279113)

Notes to the Financial Statements - continued
for the Year Ended 30th November 2023

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th November 2023 and 30th November 2022:

30.11.23 30.11.22
£    £   
Dr P R J Ames
Balance outstanding at start of year (6,204 ) (4,629 )
Amounts repaid (545 ) (1,575 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (6,749 ) (6,204 )

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr P Ames by virtue of his 100% holding of the voting share capital.